Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters








Year range
1.
Psiquiatr. salud ment ; 35(3/4): 238-243, jul.-dic. 2018.
Article in Spanish | LILACS | ID: biblio-1005047

ABSTRACT

El presente artículo trata el tema del síndrome premenstrual y su versión más grave e incapacitante: el trastorno disfórico premenstrual. Buscamos presentar los síntomas, causas y tratamientos. Resaltando la existencia de enfoques diversos. Algunos de los cuales sorprenden por su falta en efectividad, mientras que otros por lo bueno del pronóstico. Palabras claves: Trastorno Disfóricos Premenstrual, síndrome premenstrual.


This article is about premenstrual syndrome and its most serious and incapacitating version: premenstrual dysphoric disorder. We are searching for the symptoms, causes and treatments. Highlighting the existence of diverse approaches. Some of which surprise for their lack of effectiveness, while others for the good of the forecast


Subject(s)
Humans , Premenstrual Dysphoric Disorder/diagnosis , Premenstrual Dysphoric Disorder/etiology , Premenstrual Dysphoric Disorder/therapy , Premenstrual Syndrome
3.
Vertex rev. argent. psiquiatr ; 25(117): 370-6, 2014 Sep-Oct.
Article in Spanish | LILACS, BINACIS | ID: biblio-1177006

ABSTRACT

Premenstrual syndrome is characterized by physical, cognitive, affective and behavioral symptoms that occur cyclically during the luteal phase of the menstrual cycle and resolved quickly at the beginning or within few days after menstruation started. The most severe form is represented by premenstrual dysphoric disorder included in the DSM 5. Over 40


of women experience emotional symptoms such as irritability, tension, emotional lability; and physical symptoms such as breast tenderness, fatigue, and abdominal distension. It has not yet been established the underlying pathophysiological mechanism, although hypotheses related to sex hormones and the GABAergic and serotonergic regulation have been postulated. Treatment includes nonpharmacologic and pharmacologic interventions, being serotonin reuptake inhibitors the first-line treatment.


Subject(s)
Female , Humans , Premenstrual Syndrome , Premenstrual Syndrome/diagnosis , Premenstrual Syndrome/physiopathology , Premenstrual Syndrome/therapy , Premenstrual Dysphoric Disorder/diagnosis , Premenstrual Dysphoric Disorder/physiopathology , Premenstrual Dysphoric Disorder/therapy
SELECTION OF CITATIONS
SEARCH DETAIL